A 55-year-old man with newly diagnosed gastric adenocarcinoma has tumour HER2 testing performed. The tumour is HER2-positive (IHC 3+). He has inoperab...

Question

A 55-year-old man with newly diagnosed gastric adenocarcinoma has tumour HER2 testing performed. The tumour is HER2-positive (IHC 3+). He has inoperable metastatic disease. What targeted therapy should be added to first-line chemotherapy?

Accepted Answer

Trastuzumab

Answer

Bevacizumab

Answer

Ramucirumab

Answer

Cetuximab

Answer

Pembrolizumab

uk-sce-gastroenterology MCQ (SBA): Gastric Adenocarcinoma

A 55-year-old man with newly diagnosed gastric adenocarcinoma has tumour HER2 testing performed. The tumour is HER2-positive (IHC 3+). He has inoperable metastatic disease. What targeted therapy should be added to first-line chemotherapy?